Wolverine Trading’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-14,700
Closed -$285K 4565
2020
Q2
$285K Buy
+14,700
New +$263K ﹤0.01% 3404
2020
Q1
Sell
-7,200
Closed -$342K 4687
2019
Q4
$342K Sell
7,200
-5,200
-42% -$234K ﹤0.01% 3446
2019
Q3
$569K Buy
12,400
+5,600
+82% +$260K ﹤0.01% 2501
2019
Q2
$356K Sell
6,800
-15,400
-69% -$903K ﹤0.01% 3089
2019
Q1
$1.53M Buy
+22,200
New +$1.49M ﹤0.01% 1740
2018
Q4
Sell
-11,800
Closed -$1.37M 4517
2018
Q3
$1.37M Buy
11,800
+1,000
+9% +$113K ﹤0.01% 2020
2018
Q2
$1.17M Hold
10,800
﹤0.01% 2093
2018
Q1
$1.17M Buy
+10,800
New +$1.2M ﹤0.01% 2093
2017
Q4
Sell
-4,500
Closed -$444K 4979
2017
Q3
$444K Buy
4,500
+400
+10% +$38.8K ﹤0.01% 2747
2017
Q2
$409K Sell
4,100
-1,800
-31% -$194K ﹤0.01% 2637
2017
Q1
$673K Sell
5,900
-1,200
-17% -$139K ﹤0.01% 2078
2016
Q4
$852K Sell
7,100
-100
-1% -$11.1K ﹤0.01% 2065
2016
Q3
$795K Buy
7,200
+1,300
+22% +$150K ﹤0.01% 2111
2016
Q2
$716K Buy
+5,900
New +$712K ﹤0.01% 1876

Other funds holding CLB

Wolverine Trading's CLB Position: Q1 2020 in Review

Wolverine Trading sold out of Core Laboratories (CLB) in Q1 2020, closing a stake of 10,996 shares — an estimated $308K sold.

Wolverine Trading first reported a position in CLB in Q3 2016 and held it in 7 quarters. The position peaked at $1.04M in Q3 2018. 207 funds tracked by Wall St. Rank hold CLB as of Q1 2020.

  • Wolverine Trading reported no remaining Core Laboratories position as of Q1 2020 after selling out during the quarter.
  • Wolverine Trading sold 10,996 Core Laboratories shares in Q1 2020, an estimated $308K.
  • Wolverine Trading first reported a position in Core Laboratories in Q3 2016 and held it in 7 quarters.
  • Wolverine Trading's Core Laboratories position peaked at $1.04M in Q3 2018.
  • 207 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2020.

Based on Wolverine Trading's 13F filing for Q1 2020, filed 11 May 2020.